Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience - de Castro, T; Jochheim, L; Bathon, M (Ther Adv Med Oncol, 2022)
et al.